Analyst Consensus ?
ConsensusBuy32 ratings
Bullish2475.0%
Neutral825.0%
Bearish00.0%
FN2 Earnings Intelligence
Marathon Petroleum Corporation (MPC) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Jul 29, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Goldman Sachs | Buy | Buy | Maintain | Jul 22, 2026 |
| TD Cowen | Buy | Buy | Maintain | Jul 21, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Jul 14, 2026 |
| Raymond James | Outperform | Outperform | Maintain | Jul 13, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Jul 13, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 13, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jun 12, 2026 |
| Mizuho | Neutral | Neutral | Maintain | May 27, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | May 6, 2026 |
| Scotiabank | Sector Outperform | Sector Outperform | Maintain | Apr 22, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | Apr 9, 2026 |
| UBS | Buy | Buy | Maintain | Apr 2, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Feb 9, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | Sep 3, 2025 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Jul 14, 2025 |
| JP Morgan | Neutral | Neutral | Maintain | Oct 9, 2024 |
| Jefferies | Buy | Buy | Maintain | Jul 15, 2024 |
| RBC Capital | Outperform | Outperform | Maintain | Aug 2, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Feb 1, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | May 4, 2022 |
| Macquarie | Outperform | Outperform | Maintain | Feb 6, 2019 |
| Standpoint Research | Buy | Accumulate | Maintain | Dec 26, 2018 |
| Bank of America | Buy | Neutral | Upgrade | May 10, 2018 |
| Deutsche Bank | Buy | Buy | Maintain | Mar 19, 2018 |
| PiperJaffray | Neutral | Neutral | Maintain | Sep 16, 2016 |
| Scotia Howard Weil | Sector Outperform | Sector Perform | Upgrade | Dec 15, 2015 |
| Oppenheimer | Outperform | Perform | Upgrade | May 27, 2015 |
| S&P Capital IQ | Buy | Hold | Upgrade | Jul 3, 2014 |
| Imperial Capital | Outperform | In Line | Upgrade | Jan 31, 2014 |
| ISI Group | Buy | Neutral | Upgrade | Jan 30, 2014 |
| Simmons & Co. | Overweight | Neutral | Upgrade | Dec 2, 2013 |
| Tudor Pickering | Buy | Buy | Maintain | Jul 23, 2012 |
Upside is calculated against the persisted previous close $306.05. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Piper Sandler | Analyst unavailable | $343 | $315.82 | +12.1% | Jul 23, 2026 |
| Raymond James | Justin Jenkins | $335 | $294.06 | +9.5% | Jul 13, 2026 |
| Barclays | Analyst unavailable | $289 | $283.74 | -5.6% | Jul 13, 2026 |
| Jefferies | Analyst unavailable | $335 | $283.74 | +9.5% | Jul 12, 2026 |
| UBS | Manav Gupta | $321 | $280.61 | +4.9% | Jul 10, 2026 |
| Wells Fargo | Sam Margolin | $344 | $263.58 | +12.4% | Jun 15, 2026 |
| Morgan Stanley | Analyst unavailable | $265 | $260.81 | -13.4% | Jun 12, 2026 |
| Mizuho Securities | Analyst unavailable | $284 | $248.05 | -7.2% | May 27, 2026 |
| UBS | Analyst unavailable | $285 | $249.32 | -6.9% | May 6, 2026 |
| Barclays | Analyst unavailable | $270 | $260.51 | -11.8% | May 6, 2026 |
| Morgan Stanley | Joe Laetsch | $233 | $221.1 | -23.9% | Apr 24, 2026 |
| Barclays | Analyst unavailable | $230 | $220.27 | -24.8% | Apr 10, 2026 |
| Piper Sandler | Analyst unavailable | $228 | $223.52 | -25.5% | Apr 9, 2026 |
| BMO Capital | Phillip Jungwirth | $225 | $203.91 | -26.5% | Feb 9, 2026 |
| UBS | Manav Gupta | $221 | $203.63 | -27.8% | Feb 6, 2026 |
| Wells Fargo | Analyst unavailable | $217 | $187.58 | -29.1% | Feb 4, 2026 |
| Scotiabank | Paul Cheng | $174 | $176.1 | -43.1% | Jan 16, 2026 |
| Mizuho Securities | Analyst unavailable | $205 | $175.54 | -33.0% | Jan 13, 2026 |
| Piper Sandler | Analyst unavailable | $184 | $172.51 | -39.9% | Jan 8, 2026 |
| Mizuho Securities | Analyst unavailable | $196 | $186.97 | -36.0% | Dec 12, 2025 |
| Raymond James | Justin Jenkins | $200 | $184.54 | -34.7% | Nov 4, 2025 |
| Raymond James | Justin Jenkins | $203 | $181.15 | -33.7% | Oct 17, 2025 |
| Barclays | Theresa Chen | $194 | $180.89 | -36.6% | Oct 13, 2025 |
| Scotiabank | Analyst unavailable | $189 | $189.06 | -38.2% | Oct 9, 2025 |
| Morgan Stanley | Analyst unavailable | $200 | $192.24 | -34.7% | Oct 3, 2025 |
| UBS | Analyst unavailable | $220 | $196.44 | -28.1% | Sep 26, 2025 |
| Evercore ISI | Stephen Richardson | $170 | $167.42 | -44.5% | Jun 18, 2025 |
| Raymond James | Analyst unavailable | $193 | $147.35 | -36.9% | Mar 27, 2025 |
| Barclays | Analyst unavailable | $161 | $141.15 | -47.4% | Mar 14, 2025 |
| Morgan Stanley | Joe Laetsch | $174 | $151.06 | -43.1% | Dec 19, 2024 |
| Bank of America Securities | Jean Ann Salisbury | $174 | $157.9 | -43.1% | Oct 17, 2024 |
| Scotiabank | Paul Cheng | $170 | $162.61 | -44.5% | Oct 10, 2024 |
| Piper Sandler | Ryan Todd | $145 | $164.22 | -52.6% | Sep 24, 2024 |
| UBS | Manav Gupta | $189 | $163.58 | -38.2% | Sep 14, 2024 |
| Wolfe Research | Doug Leggate | $200 | $165.56 | -34.7% | Jul 17, 2024 |
| Jefferies | Lloyd Byrne | $231 | $165.46 | -24.5% | Jul 14, 2024 |
| Wells Fargo | Roger Read | $196 | $164.29 | -36.0% | Jul 12, 2024 |
| Mizuho Securities | Nitin Kumar | $201 | $172.45 | -34.3% | Jun 20, 2024 |
| Piper Sandler | Ryan Todd | $168 | $168.9 | -45.1% | Jun 14, 2024 |
| Raymond James | Justin Jenkins | $230 | $174.66 | -24.8% | May 30, 2024 |
| Piper Sandler | Ryan Todd | $190 | $177.86 | -37.9% | May 14, 2024 |
| Mizuho Securities | Nitin Kumar | $203 | $179.56 | -33.7% | May 13, 2024 |
| Barclays | Theresa Chen | $195 | $182.55 | -36.3% | May 6, 2024 |
| Mizuho Securities | Nitin Kumar | $202 | $212.27 | -34.0% | Apr 12, 2024 |
| Piper Sandler | Ryan Todd | $204 | $216.25 | -33.3% | Apr 5, 2024 |
| Wells Fargo | Roger Read | $227 | $214.96 | -25.8% | Apr 4, 2024 |
| Mizuho Securities | Nitin Kumar | $160 | $128.38 | -47.7% | Mar 10, 2023 |
| UBS | Manav Gupta | $165 | $129.41 | -46.1% | Mar 9, 2023 |
| Cowen & Co. | Analyst unavailable | $143 | $123.85 | -53.3% | Feb 1, 2023 |
| Wells Fargo | Analyst unavailable | $153 | $125.67 | -50.0% | Feb 1, 2023 |
| Raymond James | Analyst unavailable | $165 | $128.52 | -46.1% | Feb 1, 2023 |
| Raymond James | Analyst unavailable | $155 | $122.08 | -49.4% | Jan 13, 2023 |
| Piper Sandler | Analyst unavailable | $143 | $109.75 | -53.3% | Dec 19, 2022 |
| Wells Fargo | Roger Read | $117 | $95.79 | -61.8% | Aug 16, 2022 |
| BMO Capital | Phillip Jungwirth | $135 | $84.48 | -55.9% | Jun 29, 2022 |
| Wells Fargo | Roger Read | $129 | $102.17 | -57.9% | Jun 14, 2022 |
| Credit Suisse | Analyst unavailable | $110 | $93.42 | -64.1% | May 4, 2022 |
| Citigroup | Analyst unavailable | $108 | $84.86 | -64.7% | Apr 26, 2022 |
| Morgan Stanley | Connor Lynagh | $115 | $84.08 | -62.4% | Apr 25, 2022 |
| Wells Fargo | Analyst unavailable | $110 | $90.98 | -64.1% | Apr 21, 2022 |
| Citigroup | Prashant Rao | $85 | $72.81 | -72.2% | Jan 19, 2022 |
| Barclays | Theresa Chen | $80 | $72.16 | -73.9% | Jan 11, 2022 |
| Bank of America Securities | Doug Leggate | $88 | $69.93 | -71.2% | Jan 10, 2022 |
| UBS | Lloyd Byrne | $73 | $63.11 | -76.1% | Nov 17, 2021 |
| Goldman Sachs | Neil Mehta | $73 | $62.66 | -76.1% | Nov 3, 2021 |
| Wolfe Research | Sam Margolin | $68 | $55.29 | -77.8% | May 4, 2021 |
Track every rating change on MPC the moment it posts. Free to start.
Start free